Author:
Liu Yuan,Bi Yan-meng,Pan Ting,Zeng Ting,Mo Chan,Sun Bing,Gao Lei,Lyu Zhi-ping
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference41 articles.
1. Sun J, Xie Q, Tan D, Ning Q, Niu J, Bai X, et al. The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study. Hepatology 2014;59:1283–1292.
2. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425–436.
3. Rockey DC. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol 2013;11:224–231.
4. Ye B, Zhang Y, He W. Advances in research on Dicliptera chinensis (L.) Juss. China Pract Med (Chin) 2011;6:235–237.
5. Xu D, He Y, Yang S, Li K, Yang X, Shen Z. Protective effect of Dicliptera chinensis (L.) Juss. Polysaccharide P2B on carbon tetrachloride-induced injury of liver cell line L-02. China Pharm (Chin) 2016;19:675–677.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献